Content overview
Basic principle
Workflow overview
Automation
Proof of principle
Products
Content
- Basic principle
- Workflow overview
- Automation
- Proof of principle
- Products
StraightFrom REAlease Technology eliminates the need for time-consuming density-gradient centrifugation and offers full flexibility in cell labeling. The purified target cells are bead free, making them ideal for consecutive isolations, and label-free, preserving epitopes for downstream applications. The isolated cells are perfectly suited for flow cytometry, molecular biology, and functional studies.
Content overview
Basic principle
Workflow overview
Automation
Proof of principle
Products
REAlease Technology utilizes engineered antibody fragments with low affinity for epitopes in their monomeric state. When assembled into a multimeric, biotinylated REAlease Complex, these fragments bind strongly to target cell epitopes, enabling high-avidity binding. Combined with an anti-Biotin MicroBead, this complex magnetically labels target cells, allowing for efficient magnetic isolation as the labeled cells are retained in the column and separated from non-labeled cells.
To obtain MicroBead-free target cells, the REAlease Bead Release Reagent is applied during the elution step, removing anti-Biotin MicroBeads and leaving the cells ready for further applications. For completely label-free cells, the REAlease Release Reagent can be used, causing monomerization of the antibody fragments and dissociation of the complex from the cell surface. This process leaves cells free of any magnetic or antibody labels, with epitopes available for re-labeling or any additional downstream applications.
This innovative approach allows for flexible, positive selection of target cells, followed by easy removal of beads and labels, ensuring that both positively and negatively selected cells remain suitable for further separation and functional analysis.
Traditional methods involve isolating PBMCs with tedious density-gradient centrifugation before targeting specific cells. In contrast, our breakthrough StraightFrom REAlease Technology skips this time-consuming step, providing bead-free target cells directly from blood in just 40 minutes. Using positive selection and the REAlease Biotin Complex, this innovative approach delivers fast, efficient, and hassle-free cell isolation. Leukocyte subsets can then be isolated manually with MACS Separators or automated with the autoMACS NEO or the MultiMACS Cell24 Separator Plus, providing full flexibility for your workflow. Learn more about automation below.
The workflow shown gives a general visual overview of the protocol. For specific details, please refer to the data sheet included with your StraightFrom Kit.
Add automation to your workflow to enhance efficiency. The autoMACS® NEO Separator offers true walk-away automation for small to medium sample volumes, making cell separation simple, reliable, and hands-free. It delivers consistent results while saving valuable hands-on time. For larger volumes, the MultiMACS™ Cell24 Separator Plus streamlines cell isolation with a semi-automated workflow. Designed to process an entire buffy coat in one run, it delivers bead-free cell populations with high purity and recovery in just 40 minutes. Equipped with Whole Blood Columns, it ensures speed, reliability, and reproducibility for large-volume cell isolation, bringing consistency to your daily workflows.
CD3+ cells were isolated from a complete buffy coat using the StraightFrom Buffy Coat REAlease CD3 MicroBead Kit, Whole Blood Columns, and a MultiMACS Cell24 Separator Plus with the Single-Column Adapter. Cells were fluorescently stained with REAfinity Antibodies CD3-PE and Biotin-APC-Vio 770 (for recognition of the REAlease Biotin Complex) and analyzed by flow cytometry using the MACSQuant® Analyzer X. Cell debris and dead cells were excluded from the analysis based on scatter signals and propidium iodide fluorescence. Directly after isolation, the cells showed staining of biotin (MicroBead-free CD3+ cells), whereas the label-free CD3+ cells after the REAlease Biotin Complex release were negative for biotin similar to the non-labeled cells before separation.
Label-free CD3+ T cells isolated with the StraightFrom Buffy Coat REAlease CD3 MicroBead Kit, human, remain non-activated (showing nearly no CD25/CD69 expression) for 2 to 3 days after isolation, similar to untouched T cells obtained with the Pan T Cell Isolation Kit, human, from the same blood sample. After 2 to 3 days of isolation and stimulation, both label-free and untouched T cells displayed the same high activation levels, with increased CD25/CD69 expression and reduced CD3 MFI.
In the same way, CD4+ and CD8+ unlabeled cells showed low activation levels, comparable to untouched cells when unstimulated for 2 days. After 2 days of isolation and stimulation, both cell types reached similar activation levels. This was observed when comparing the StraightFrom Buffy Coat REAlease CD4 or CD8 MicroBead Kits, human, with the CD4+ or CD8+ T Cell Isolation Kits, human, using the same buffy coats (results not shown).
11 products found
|
You have previously chosen International as your location.
What do you want to do?